Summary
In this short article for an Australian nursing magazine, New Zealand mental health nurse Jason Watson challenges the idea that withholding gender-affirming treatment from young people drives them to suicide. He looks at six large, long-term studies from the Netherlands, Sweden, Denmark, the UK and Finland. In his reading, suicide rates among transgender people stayed well above the general population after treatment, rates fell over time only for trans women in one Dutch study, and the Tavistock clinic review found no rise in youth suicides after access to puberty blockers was restricted in England. He concludes that the 'transition or suicide' claim is weak at best. The article was printed in July 2026, then removed from the journal's website after complaints; the nurses' union apologised for publishing it but later said this did not imply misconduct by the author. It is an opinion piece, not a systematic review: it picks a handful of studies, most of them about adults, and some of its readings go further than the studies' own authors. For example, the Finnish study it relies on most concluded that suicide risk was explained by mental illness and that gender reassignment did not change suicide risk either way.
Key findings
- ワトソン氏は、性別を肯定する治療を受けられない若者は自殺リスクが高いという、WPATHや米国の保健当局者が述べて広く繰り返されている主張に疑問を呈している。
- オランダ、スウェーデン、デンマーク、英国、フィンランドの6件の長期追跡研究を検討している。対象は324人から1万5,000人超、追跡期間は5年から46年に及ぶ。
- トランスジェンダーの人々の自殺率と死亡率は、治療後も一般人口より高いままだったと報告している。時間の経過とともに自殺が減少したのは、トランス女性を対象としたオランダの研究1件のみだった。
- 英国のタヴィストック・クリニックでの自殺に関する検証を取り上げている。それによると自殺は12件で、急増するという予測にもかかわらず、思春期ブロッカーが制限された後に若者の自殺は増えていなかった。
- 「移行か自殺か」という語りは「せいぜい根拠が乏しく、最悪の場合は単に誤りである」と結論づけており、この分野の研究の大半は質が低いとするキャス・レビューの所見と一致するとしている。
- オーストラリアの看護師労働組合は2026年7月に記事を会報誌のウェブサイトから削除して掲載を謝罪し、その後、著者の不正行為が認定されたわけではないと説明した。
Abstract
This short article examines the narrative that trans youth who are not provided with gender-affirming healthcare face an increased risk of suicide, a view stated by WPATH's Standards of Care 8 and the US Assistant Secretary for Health in 2022. Noting the Cass Review's finding that research in this field is of poor quality, the author summarises six long-term follow-up studies from the Netherlands (Wiepjes 2020; de Blok 2021), Sweden (Dhejne 2011), Denmark (Erlangsen 2023), England (Appleby 2024, a review of suicides among Tavistock gender clinic patients) and Finland (Ruuska 2024), with sample sizes from 324 to 15,032 and follow-up from five to 46 years, and describes what each reported about suicide and mortality.
Conclusion
Only one finding, the decline in suicide among trans women over time in Wiepjes (2020), appeared to support the narrative that lack of access to gender-affirming care increases suicide risk. The author argues the other studies showed no evidence that treatment reduced suicidal behaviour, and reported higher 'other' mortality after treatment, and that Ruuska (2024), the only study with a matched control group, found much higher suicide and overall mortality among trans people. He concludes the 'trans suicide narrative' is 'at least tenuous and at most simply incorrect', consistent with the Cass Review's view that most research in this field is of poor quality.